Metrasens Launches Metrasens Ultra™ Detection System into Healthcare
Summary
Metrasens Ultra, with limited release beginning in 2021, has now reached nearly 1,000 deployed systems around the world and has proven its efficacy in both detection performance as well as design aesthetics, both of which are key factors advocated for by cross functional hospital leadership. Xact ID, Ultra’s unmatched technology component, was developed with system intelligence that drives performance through advanced software algorithms, machine learning, and sensor design. Usage of Metrasens Ultra by in-house or third-party security staff is a snap, with an intuitive user interface and easy to interpret zone indication LED’s that provide location on the body where a threat object is detected, taking away the guesswork and valuable time often wasted in secondary searches. With a technology center and manufacturing facility in the United Kingdom, a North American sales and customer service hub in Chicago and a global network of distributors, the company’s innovative products are designed to address deficiencies in conventional screening methods and make the world safer and more secure. Metrasens’ mission is to take cutting-edge science from the laboratory and use it to create revolutionary, award-winning products that meet the distinct and diverse security needs of its customers.